SpheroFill Insights

SpheroFill Insights

By SpheroFillScienceChemistry
Download on the App Store

SpheroFill Insights episodes

  • Mesoporous Silica versus SpheroFill PWHGMs

    It may surprise you to learn that silica glass is already widely used in foods and pharmaceuticals, but what happens when scientists engineer it to carry medicine? Explore the fascinating differences between conventional mesoporous silica “sponges” and SpheroFill’s porous-wall hollow glass microspheres (PWHGMs). Discover how a fundamentally different particle architecture creates new possibilities for drug loading, protection, and controlled release—and why these two technologies might someday work even better together.  SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.

    13 min
  • Tiny Bubbles, Big Possibilities: Introducing Porous-Wall Hollow Glass Microspheres

    What if tiny glass bubbles originally developed for homeland defense purposes could help solve some of the biggest challenges in modern medicine? In this inaugural episode of SpheroFill Insights, discover the remarkable science behind porous-wall hollow glass microspheres (PWHGMs)—microscopic silica containers with hollow interiors and nanoscale channels that open intriguing possibilities for pharmaceutical drug delivery. From protecting fragile medicines and controlling drug release to targeting specific tissues and potentially enabling personalized, multi-drug therapies, explore how an ingenious piece of materials engineering could inspire new approaches to delivering tomorrow's medicines.

    SpheroFill Insights makes use of AI-generated voiceover technology from JellyPod.

    16 min

About SpheroFill Insights

From the publisher's feed

Spherofill Insights is a science-focused podcast series exploring the challenges of modern pharmaceutical drug delivery and the potential of emerging technologies to address them. Through engaging conversations between a physician-innovator and a pharmaceutical formulation scientist, each episode examines current peer-reviewed research, existing treatment and formulation strategies, and important unmet needs in drug development.